Quantum BioPharma Ltd.
QNTM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $61 | $9 | $4 |
| - Cash | $0 | $1 | $4 | $6 |
| + Debt | $0 | $2 | $1 | $1 |
| Enterprise Value | – | $62 | $7 | -$1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$4 | -$9 | -$8 | -$5 |
| % Margin | – | – | – | – |
| Net Income | -$5 | -$9 | -$9 | -$5 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.25 | -3.23 | -7.52 | -5.22 |
| % Growth | 61.3% | 57% | -44.1% | – |
| Operating Cash Flow | -$2 | -$2 | -$4 | -$1 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$2 | -$2 | -$4 | -$1 |